Intco Medical Technology Co Ltd
SZSE:300677
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20.71
45.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intco Medical Technology Co Ltd
Revenue
Intco Medical Technology Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Revenue
ÂĄ9.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Revenue
ÂĄ13.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
S
|
Shanghai Conant Optical Co Ltd
HKEX:2276
|
Revenue
ÂĄ2.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Revenue
ÂĄ4.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Revenue
ÂĄ9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Revenue
ÂĄ4.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
24%
|
|
Intco Medical Technology Co Ltd
Glance View
In the bustling industrial landscape of China, Intco Medical Technology Co., Ltd. has carved a distinctive niche as a significant player in the production and global distribution of disposable medical products. Established in 2009, the company has orchestrated its growth strategy by focusing on the manufacture of essential medical consumables like gloves, face masks, thermal plastics, and non-woven products. Intco's operations are adeptly integrated, with facilities strategically located to optimize manufacturing efficiencies and logistical ease, facilitating swift distribution to over 100 countries. This strategic footprint ensures that products are rapidly dispatched to meet the ever-increasing demands of global healthcare markets. Driving the company’s financial engine is its diversified product portfolio, tailored to cater to a wide array of healthcare needs, from hospitals to individual consumers who prioritize personal health safety. The company monetizes its offerings through a robust sales network, leveraging both direct sales channels and partnerships with global distributors. While the COVID-19 pandemic played a role in increasing demand for personal protective equipment, Intco has sustained its profitability through a commitment to quality and innovation, continuously expanding its research and development initiatives. By maintaining a balance between high-volume production and stringent quality control, Intco Medical Technology thrives as a cornerstone in the healthcare supply chain, adeptly navigating the dynamics of a rapidly evolving industry.
See Also
What is Intco Medical Technology Co Ltd's Revenue?
Revenue
9.8B
CNY
Based on the financial report for Sep 30, 2025, Intco Medical Technology Co Ltd's Revenue amounts to 9.8B CNY.
What is Intco Medical Technology Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
1%
Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Intco Medical Technology Co Ltd have been 8% over the past three years , 1% over the past five years .